User:Mr. Ibrahem/Evolocumab

Evolocumab, sold under the brand name Repatha, is a medication used to treat abnormal lipids and prevent heart disease. It is less preferred to statins. It is given by injection under the skin every 2 weeks or once a month.

Common side effects include runny nose, upper respiratory tract infection, back pain, and pain at the site of injection. Other side effects may include allergic reactions. Safety in pregnancy is unclear. It is a monoclonal antibody that attaches to and blocks proprotein convertase subtilisin/kexin type 9 (PCSK9).

Evolocumab was approved for medical use in the United States and Europe in 2015. In the United Kingdom it costs the NHS about £340 every 4 weeks as of 2021. This amount in the United States is about 470 USD.